Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 6.07372 | 83 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 6.14888 | 83 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 6.20093 | 84 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 6.38979 | 84 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 6.5527 | 86 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 6.27581 | 86 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 6.14873 | 85 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 6.41446 | 86 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.95526 | 82 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 6.50298 | 86 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 6.34243 | 85 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 6.18968 | 83 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.5824 | 80 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 6.03531 | 83 |